In conjunction with AACC/ASCLS Annual Meetings and Clinical Lab Expo

Join CLSI President Gerald A. Hoeltge, MD and experts from the US Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS), industry, and the professions to hear the accomplishments, challenges, and strategies for advancing quality performance in medical laboratories. Focus on implementation of laboratory practices, certification of medical laboratories, and regulation of in vitro diagnostic (IVD) tests. Includes updates on the progress of CLSI's documents EP22 and EP23.

Quality
Perspectives on ensuring quality clinical and laboratory performance from CLSI, CMS, and FDA experts.

CLSI Updates: EP22 and EP23
The scope and issues being addressed during the development of new CLSI guidelines EP22 and EP23 focusing on quality control based on risk management. Includes practical values of the guidelines to industry, government regulatory, and medical laboratories.

Accreditation Preparedness
How to avoid the most commonly cited deficiencies during laboratory accreditation inspections.

IVD Regulation
FDA's role in assuring effectiveness and safety of IVD tests.

Featured Speakers

• Gerald A. Hoeltge, MD, President, CLSI
  Co-Director, Transfusion Medicine, Cleveland Clinic
  
• Greg Cooper, CLS, MHA
  Manager, Clinical Standards and Practices, Bio-Rad Laboratories, Inc., Quality Systems Division
  
• James H. Nichols, PhD, DABCC, FACB
  Director, Clinical Chemistry, Baystate Medical Center
  
• Judith A. Yost, MA, MT(ASCP)
  Director, Division Laboratory Services, Centers for Medicare & Medicaid Services
  
• Alberto Gutierrez, PhD
  Deputy Director, Premarket Program, Office of In Vitro Diagnostic Device Evaluation and Safety

Learn More and Sign Up Today

Visit CLSI at the Clinical Lab Expo booth number 3933 during the AACC and ASCLS Annual Meetings 29-30 July.